232 related articles for article (PubMed ID: 34572905)
1. Tumor Microenvironment of Esophageal Cancer.
Schiffmann LM; Plum PS; Fuchs HF; Babic B; Bruns CJ; Schmidt T
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572905
[TBL] [Abstract][Full Text] [Related]
2. Esophageal Cancer: New Insights into a Heterogenous Disease.
Krug S; Michl P
Digestion; 2017; 95(4):253-261. PubMed ID: 28384630
[TBL] [Abstract][Full Text] [Related]
3. Esophageal Tumor Microenvironment.
Nienhüser H; Wirsik N; Schmidt T
Adv Exp Med Biol; 2020; 1296():103-116. PubMed ID: 34185288
[TBL] [Abstract][Full Text] [Related]
4. Loss of ARID1A expression is associated with DNA mismatch repair protein deficiency and favorable prognosis in advanced stage surgically resected esophageal adenocarcinoma.
Lowenthal BM; Nason KS; Pennathur A; Luketich JD; Pai RK; Davison JM; Ma C
Hum Pathol; 2019 Dec; 94():1-10. PubMed ID: 31655170
[TBL] [Abstract][Full Text] [Related]
5. The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation.
Kelly RJ; Zaidi AH; Smith MA; Omstead AN; Kosovec JE; Matsui D; Martin SA; DiCarlo C; Werts ED; Silverman JF; Wang DH; Jobe BA
Ann Surg; 2018 Dec; 268(6):992-999. PubMed ID: 28806299
[TBL] [Abstract][Full Text] [Related]
6. Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.
Ilson DH; van Hillegersberg R
Gastroenterology; 2018 Jan; 154(2):437-451. PubMed ID: 29037469
[TBL] [Abstract][Full Text] [Related]
7. The tumor microenvironment in esophageal cancer.
Lin EW; Karakasheva TA; Hicks PD; Bass AJ; Rustgi AK
Oncogene; 2016 Oct; 35(41):5337-5349. PubMed ID: 26923327
[TBL] [Abstract][Full Text] [Related]
8. The immunological impact of neoadjuvant chemotherapy on the tumor microenvironment of esophageal squamous cell carcinoma.
Tsuchikawa T; Miyamoto M; Yamamura Y; Shichinohe T; Hirano S; Kondo S
Ann Surg Oncol; 2012 May; 19(5):1713-9. PubMed ID: 21822560
[TBL] [Abstract][Full Text] [Related]
9. A study of the immune infiltrate and patient outcomes in esophageal cancer.
Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for Esophageal Cancer: State-of-the Art in 2021.
Teixeira Farinha H; Digklia A; Schizas D; Demartines N; Schäfer M; Mantziari S
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158822
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?].
Babic B; Fuchs HF; Bruns CJ
Chirurg; 2020 May; 91(5):379-383. PubMed ID: 32140748
[TBL] [Abstract][Full Text] [Related]
12. Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis.
Li J; Zeng Z; Jiang X; Zhang N; Gao Y; Luo Y; Sun W; Li S; Ren J; Gong Y; Xie C
Sci Rep; 2020 Oct; 10(1):18589. PubMed ID: 33122682
[TBL] [Abstract][Full Text] [Related]
13. Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche.
Han P; Cao P; Hu S; Kong K; Deng Y; Zhao B; Li F
Cancer Manag Res; 2020; 12():5857-5879. PubMed ID: 32765088
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer.
van den Ende T; Smyth E; Hulshof MCCM; van Laarhoven HWM
Best Pract Res Clin Gastroenterol; 2018; 36-37():45-52. PubMed ID: 30551856
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Treatment for Locally Invasive Esophageal Cancer.
Iams WT; Villaflor VM
World J Surg; 2017 Jul; 41(7):1719-1725. PubMed ID: 28271259
[TBL] [Abstract][Full Text] [Related]
16. Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer.
Blum Murphy MA; Elimova E; Ajani JA
Expert Rev Gastroenterol Hepatol; 2016; 10(3):383-92. PubMed ID: 26560689
[TBL] [Abstract][Full Text] [Related]
17. Stromal fibroblasts are predictors of disease-related mortality in esophageal squamous cell carcinoma.
Saito S; Morishima K; Ui T; Matsubara D; Tamura T; Oguni S; Hosoya Y; Sata N; Lefor AT; Yasuda Y; Niki T
Oncol Rep; 2014 Jul; 32(1):348-54. PubMed ID: 24859885
[TBL] [Abstract][Full Text] [Related]
18. Perioperative and Palliative Chemotherapy for Esophageal Cancer.
Behrens A; Ell C; Lordick F
Viszeralmedizin; 2015 Oct; 31(5):341-6. PubMed ID: 26989390
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancer.
Tsuchikawa T; Takeuchi S; Nakamura T; Shichinohe T; Hirano S
World J Gastrointest Oncol; 2016 Nov; 8(11):786-792. PubMed ID: 27895816
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
